Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Crosses Above 200 Day Moving Average – What’s Next?

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.39 and traded as high as $2.43. Cumberland Pharmaceuticals shares last traded at $2.32, with a volume of 168,176 shares changing hands.

Analyst Ratings Changes

Separately, StockNews.com started coverage on shares of Cumberland Pharmaceuticals in a research report on Friday. They issued a “hold” rating for the company.

Cumberland Pharmaceuticals Price Performance

The firm has a market capitalization of $31.88 million, a P/E ratio of -2.95 and a beta of 0.30. The company has a quick ratio of 0.99, a current ratio of 1.13 and a debt-to-equity ratio of 0.41. The business’s 50-day simple moving average is $1.40 and its 200 day simple moving average is $1.40.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.